Remi Edelstahl Tubulars has successfully completed a preferential allotment of 8.33 lakh equity shares, raising Rs 14.99 crore. The shares were issued at Rs 180 apiece to five investors, including entities from the promoter group. Simultaneously, the company has abandoned its plans for a convertible warrant issuance after failing to receive necessary funds from one of the proposed allottees. This fresh capital infusion provides liquidity, though the cancelled warrant issuance highlights a need for investors to monitor management’s capital-raising execution.
Remi Edelstahl Secures Rs 15 Crore via Preferential Equity Allotment
Remi Edelstahl Tubulars Limited has successfully raised Rs 14.99 crore through the issuance of 8,33,331 equity shares at a price of Rs 180 per share.
The company has also officially called off its previously planned issuance of convertible warrants due to payment defaults.
Reader Takeaway: The company secured Rs 15 crore in equity, but the cancelled warrant issue raises questions about counterparty reliability.
What just happened
On September 23, 2026, the board of Remi Edelstahl Tubulars Limited finalized a preferential allotment of 8,33,331 equity shares. Each share, with a face value of Rs 10, was issued at a premium of Rs 170, totaling an issue price of Rs 180. The capital was raised from a mix of promoter group entities and external investors.
Allottees Breakdown
The fundraising saw participation from two major entities in the promoter group: Hanuman Freight & Carriers Private Limited and Skyrise Mercantile Limited. Additionally, three non-promoter entities—Jay Bharat Mehta, J B Mody Enterprises LLP, and SNS Ventures LLP—also participated in the allotment. These shares are now subject to mandatory statutory lock-in periods as per SEBI regulations.
Why the warrant issue failed
Contrasting the successful equity infusion, the company management confirmed that the proposed issuance of convertible warrants did not materialize. This decision was triggered by the failure of a proposed allottee to deposit the necessary funds. By choosing not to proceed with the warrant issuance, the company has mitigated further uncertainty regarding that specific tranche of capital.
Risks to watch
While the Rs 15 crore infusion bolsters the balance sheet, the cancellation of the warrant issue serves as a critical red flag regarding the company's capital-raising process. Investors should carefully evaluate how management vets counterparties in future financing rounds to avoid similar disruptions to planned growth capital.
What to track next
Shareholders should monitor the company’s upcoming quarterly updates to see how this fresh capital is utilized. Future filings will also provide clarity on whether the company intends to seek alternative funding routes to replace the cancelled warrant issuance.